Gut microbes impact on conventional chemotherapy; more likely to respond to imuno-therapy treatment

news_20151027_gut_bacteria_full_169Gut bacteria have been associated with a number of immune diseases and treatment of diverse medical conditions. A new study presented at the National Cancer Research Institute’s (NCRI) Cancer conference in Liverpool has highlighted the role of gut bacteria with cancer immuno-therapy treatment. Continue reading “Gut microbes impact on conventional chemotherapy; more likely to respond to imuno-therapy treatment”